Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 580 participants.
Also called NCT06202755
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 580 participants
- Sponsor
- Registry
-
NCT06202755
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Egypt
- Registry status
- Unknown status
Technical summary
Registry record NCT06202755. Randomized; double masking; primary purpose treatment. Start 2024-03-30 (actual); primary completion 2025-06-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Versus Cilostazol in Large-vessel Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Ticagrelor 90 MG
- Intervention (Drug)
- Cilostazol 100 MG
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06202755- Content hash
d28ac78e7a721d5b9b97f35056d71e982d5f3d7ba66e5f6f973aabed8961e802